| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immunovant, Inc. | Chief Operating Officer | Common Stock | 173,511 | $4,159,058 | $23.97 | 20 Nov 2025 | Direct |
| ACELYRIN, Inc. | Chief Operating Officer | Common Stock | 130,286 | $582,378 | $4.47 | 15 May 2024 | Direct |
| ACELYRIN, Inc. | Chief Operating Officer | Employee Stock Option (right to buy) | 184,042 | 23 May 2024 | Direct | ||
| Immunovant, Inc. | Chief Operating Officer | Stock Option (right to buy) | 107,297 | 01 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | 20 Nov 2025 | 2 | -$298,237 | 4 | Chief Operating Officer | 21 Nov 2025, 16:24 |
| IMVT | Immunovant, Inc. | 01 Apr 2025 | 2 | $0 | 4 | Chief Operating Officer | 03 Apr 2025, 16:53 |
| IMVT | Immunovant, Inc. | 18 Nov 2024 | 2 | $0 | 4 | Chief Operating Officer | 20 Nov 2024, 17:15 |
| IMVT | Immunovant, Inc. | 18 Nov 2024 | 0 | $0 | 3 | Chief Operating Officer | 20 Nov 2024, 17:11 |
| SLRN | ACELYRIN, Inc. | 23 May 2024 | 1 | $0 | 4 | Chief Operating Officer | 24 May 2024, 19:06 |
| SLRN | ACELYRIN, Inc. | 15 May 2024 | 1 | -$46,032 | 4 | Chief Operating Officer | 17 May 2024, 19:12 |
| SLRN | ACELYRIN, Inc. | 09 Jan 2024 | 1 | $0 | 4 | Chief Operating Officer | 11 Jan 2024, 18:31 |
| SLRN | ACELYRIN, Inc. | 16 Aug 2023 | 1 | $0 | 4 | Chief Operating Officer | 18 Aug 2023, 19:50 |
| SLRN | ACELYRIN, Inc. | 09 May 2023 | 6 | $0 | 4 | Chief Operating Officer | 11 May 2023, 20:56 |
| SLRN | ACELYRIN, Inc. | 04 May 2023 | 1 | $0 | 4 | Chief Operating Officer | 04 May 2023, 20:03 |
| SLRN | ACELYRIN, Inc. | 04 May 2023 | 0 | $0 | 3 | Chief Operating Officer | 04 May 2023, 18:50 |